Kim Rathmell, MD
Research Interests
Key words: Renal cell carcinoma, von Hippel-Landau tumor suppressor gene, biologically active treatment protocols The focus of my research group is the understanding of the tumorigenesis of renal cell carcinoma. We tackle this problem using a variety of approaches, utilizing genetically engineered cells and mice. These models provide tools with which we are able to investigate the effects of the von Hippel-Lindau and other important genes on processes integral to tumorigenesis including angiogenesis, vasculogenesis, hypoxic response signaling, extracellular matrix remodeling, glucose metabolism, and cell cycle signaling. These genetic models additionally provide the platform for the generation of a series of VHL mutant mice as an in vivo model of the human disease. Our cell culture and mouse models provide excellent models for exploring the pathogenesis of renal cancer as well as serving as tools for drug development.
Trainees:
PublicationsContact Information21-237 Lineberger Comprehensive Cancer Center Web: http://www.unc.edu/~rathmell Office: (919) 966-8644 Email: Kim Rathmell, PhD |

Associate Professor
